Surge in breast cancer among younger women sparks urgent medical investigation

The rate of breast cancer among women under 50 has surged by over 15% in the last two decades, largely driven by an increase in estrogen receptor-positive (ER+) breast cancer.

This subtype of the disease, fueled by the hormone estrogen, is raising alarms among researchers and doctors.

Dr. Alexandra Thomas, a medical oncologist at Duke Health, highlighted a significant factor: “Women are being exposed to more estrogen over their lifespans. That’s probably a big piece of it, but we don’t know why we’re seeing earlier periods.”

Earlier onset of puberty has long been linked to a higher risk of breast cancer, but there’s limited research into how it impacts the age at diagnosis.

READ ALSO: Study finds 200 breast cancer-linked chemicals in food packaging

Dr. Eleonora Teplinsky, head of breast and gynecologic medical oncology at Valley Health System in New Jersey, noted that starting menstruation before age 11 increases breast cancer risk.

The average age of menarche keeps decreasing, and that’s concerning.” Studies show that for every year younger a girl is when she starts her period, her lifetime breast cancer risk rises by about 5%.

Research into breast development adds to the concern. A study involving nearly 50,000 women found that girls who began breast development before age 10 had a 23% higher risk of developing breast cancer compared to those who started at age 12 or 13.

As the medical community races to understand these trends, more research is needed to uncover the full scope of the issue and how to counter it.